1. |
中國癡呆與認知障礙指南寫作組, 中國醫師協會神經內科醫師分會認知障礙疾病專業委員會. 2018中國癡呆與認知障礙診治指南(一): 癡呆及其分類診斷標準. 中華醫學雜志, 2018, 98(13): 965-970.
|
2. |
Gauthier S, Albert M, Fox N, et al. Why has therapy development for dementia failed in the last two decades. Alzheimers Dement, 2016, 12(1): 60-64.
|
3. |
No authors listed. 2020 Alzheimer's disease facts and figures. Alzheimers Dement, 2020.
|
4. |
GBD 2016 Dementia Collaborators. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol, 2019, 18(1): 88-106.
|
5. |
Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Standing Commission. Lancet, 2024, 404(10452): 572-628.
|
6. |
Batty GD, Shipley MJ, Kvaavik E, et al. Biomarker assessment of tobacco smoking exposure and risk of dementia death: pooling of individual participant data from 14 cohort studies. J Epidemiol Community Health, 2018, 72(6): 513-515.
|
7. |
Zhong G, Wang Y, Zhang Y, et al. Smoking is associated with an increased risk of dementia: a meta-analysis of prospective cohort studies with investigation of potential effect modifiers. PLoS One, 2015, 10(3): e0118333.
|
8. |
Mukadam N, Sommerlad A, Huntley J, et al. Population attributable fractions for risk factors for dementia in low-income and middle-income countries: an analysis using cross-sectional survey data. Lancet Glob Health, 2019, 7(5): e596-e603.
|
9. |
任汝靜, 殷鵬, 王志會, 等. 中國阿爾茨海默病報告2021. 診斷學理論與實踐, 2021, 20(4): 317-337.
|
10. |
Jia L, Du Y, Chu L, et al. Prevalence, risk factors, and management of dementia and mild cognitive impairment in adults aged 60 years or older in China: a cross-sectional study. Lancet Public Health, 2020, 5(12): e661-e671.
|
11. |
張靜雅, 魯永博, 李浩然, 等. 中國居民1990–2019年老年癡呆癥疾病負擔年齡–時期–隊列分析及預測. 中國公共衛生, 2022, 38(5): 523-528.
|
12. |
Wang M, Luo X, Xu S, et al. Trends in smoking prevalence and implication for chronic diseases in China: serial national cross-sectional surveys from 2003 to 2013. Lancet Respir Med, 2019, 7(1): 35-45.
|
13. |
Jiang Y, Man Q, Liu Z, et al. Temporal trends in the mortality rate of Alzheimer's disease and other dementias attributable to smoking, 1990-2017. Environ Res, 2020, 184: 109183.
|
14. |
尹孟凡, 崔玉蓉, 陳芝蕙, 等. 1990–2019年中國阿爾茨海默病疾病負擔及危險因素. 中華疾病控制雜志, 2024, 28(1): 32-39.
|
15. |
Li R, Qi J, Yang Y, et al. Disease burden and attributable risk factors of Alzheimer's disease and dementia in China from 1990 to 2019. J Prev Alzheimers Dis, 2022, 9(2): 306-314.
|
16. |
盧添歡, 宇傳華. 基于全球視角的中國癡呆癥疾病負擔現狀及趨勢分析. 中華疾病控制雜志, 2022, 26(6): 684-690.
|
17. |
葛珊珊, 張志將. 1990–2017年中國阿爾茨海默病疾病負擔趨勢分析. 中國慢性病預防與控制, 2021, 29(9): 718-722.
|
18. |
黃磊, 孟令昊, 歐汝威, 等. 1990–2019年中國人群阿爾茨海默病與其他癡呆癥的疾病負擔分析. 現代預防醫學, 2021, 48(14): 2515-2519.
|
19. |
Bo Z, Wan Y, Meng SS, et al. The temporal trend and distribution characteristics in mortality of Alzheimer's disease and other forms of dementia in China: based on the National Mortality Surveillance System (NMS) from 2009 to 2015. PLoS One, 2019, 14(1): e0210621.
|
20. |
沈銀. 廣州地區城鄉65歲及以上老人輕度認知障礙和癡呆的流行病學調查. 廣州: 廣州醫學院, 2011.
|
21. |
GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 2020, 396(10258): 1223-1249.
|
22. |
GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2018, 392(10159): 1923-1994.
|
23. |
袁曉霞, 周尚成, 高昭昇, 等. 2017–2019年廣州市腦卒中疾病負擔分析. 中國慢性病預防與控制, 2021, 29(6): 474-478.
|
24. |
GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 2017, 390(10100): 1345-1422.
|
25. |
中國疾病預防控制中心. 中國慢性病及其危險因素監測報告2013. 北京: 軍事醫學出版社, 2016.
|
26. |
丁賢彬, 焦艷, 毛德強, 等. 2012–2018年重慶市阿爾茨海默病死亡率及疾病負擔變化趨勢. 中國慢性病預防與控制, 2020, 28(9): 665-668.
|
27. |
王浩, 李娜, 俞佳男, 等. 2003–2017年浙江省阿爾茨海默病發病和死亡趨勢分析. 預防醫學, 2022, 34(3): 227-231,239.
|
28. |
Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet, 2020, 396(10248): 413-446.
|
29. |
國家衛生健康委員會. 2019年中國衛生統計年鑒. 北京: 中國衛生出版社, 2020.
|
30. |
Rahman A, Schelbaum E, Hoffman K, et al. Sex-driven modifiers of Alzheimer risk: a multimodality brain imaging study. Neurology, 2020, 95(2): e166-e178.
|
31. |
陳可冀, 唐希燦, 何新貴, 等. 《中國應對阿爾茨海默病戰略行動計劃》建議書. 阿爾茨海默病及相關病雜志, 2021, 4(2): 91-97.
|
32. |
張波, 張連生, 程桂榮, 等. 癡呆危險因素人群歸因分值的城鄉差異. 中華疾病控制雜志, 2021, 25(7): 854-858, 863.
|
33. |
GBD 2015 Tobacco Collaborators. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet, 2017, 389(10082): 1885-1906.
|
34. |
Ng M, Freeman MK, Fleming TD, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA, 2014, 311(2): 183-192.
|
35. |
Durazzo TC, Mattsson N, Weiner MW, et al. Smoking and increased Alzheimer's disease risk: a review of potential mechanisms. Alzheimers Dement, 2014, 10(3 Suppl): S122-S145.
|